POADOSpre: Brain Imaging of Pain-Related Processing and Structural Properties in Disc Degenerative Disease

Sponsor
Karolinska Institutet (Other)
Overall Status
Recruiting
CT.gov ID
NCT04934917
Collaborator
(none)
40
2
27.1
20
0.7

Study Details

Study Description

Brief Summary

In this study, we apply brain MR imaging techniques at 3 Tesla to assess pain-relevant processing in patients with disc degenerative disease (DDD) scheduled for back surgery and age- and gender-matched controls without back pain. Data collection pre-surgery is performed over two days: On the first day, all participants undergo a battery of questionnaires relevant for individuals with chronic pain and pain sensitivity testing, including temporal summation and pressure pain thresholds. On the second day, participants undergo a MRI protocol, which includes functional MRI (fMRI) and diffusion tensor imaging to assess microstructural properties and structural connectivity. During fMRI, an experimental pressure pain paradigm is performed at the calf i.e. a location not connected to patients' chronic pain condition. Instead, the experimental pain paradigm serves as a condition to test processing of noxious stimulation unrelated to patients' experienced chronic pain. The noxious input pressure is individually calibrated to 50 on a 0-100 VAS scale to ensure that individual pain perceptions, despite different pressure intensities, are comparable across participants. The sensory stimulation will consist of a low standardized pressure intensity (150kPa). In an additional fMRI paradigm, participants do not receive stimulation but are instructed to continuously rate fluctuating spontaneous ongoing back pain (DDD) or perceived unpleasantness (controls).

This project aims at investigating measures of brain architecture, neural response connected with evoked pain, connectivity (structural and functional) and pain-relevant psychometrics and questionnaire data in disc degenerative disease patients scheduled for back surgery. Specifically, MRI is performed to test whether i) patients display differences in properties of the mesolimbic circuit compared to healthy individuals and ii) behavioural as well as clinical characteristics related to the acquired MRI markers. This study is intended to serve as a baseline in a longitudinal project testing associations with between findings at baseline and following surgery (fusion/disc implants).

Condition or Disease Intervention/Treatment Phase
  • Device: Magnetic Resonance Imaging

Study Design

Study Type:
Observational
Anticipated Enrollment :
40 participants
Observational Model:
Case-Control
Time Perspective:
Cross-Sectional
Official Title:
Brain Imaging of Pain-Related Processing and Structural Properties in Disc Degenerative Disease
Actual Study Start Date :
Aug 28, 2019
Anticipated Primary Completion Date :
Nov 30, 2021
Anticipated Study Completion Date :
Nov 30, 2021

Arms and Interventions

Arm Intervention/Treatment
Patients with disc degenerative disease (DDD)

Patients suffering from disc degenerative disease, age 30-60 years that are on the waiting list for surgery (fusion/disc implants) at Stockholm Spine Center, Stockholm, Sweden.

Device: Magnetic Resonance Imaging
Magnetic Resonance Imaging. Pain testing: Temporal summation, Pain thresholds. Assessment of symptoms: Questionnaires. All interventions are made at baseline only (1 time/subject).

Healthy controls (HC)

Healthy controls matched according to age and sex, no chronic pain conditions.

Device: Magnetic Resonance Imaging
Magnetic Resonance Imaging. Pain testing: Temporal summation, Pain thresholds. Assessment of symptoms: Questionnaires. All interventions are made at baseline only (1 time/subject).

Outcome Measures

Primary Outcome Measures

  1. Functional magnetic resonance imaging (rsfMRI) [Baseline]

    Analysis of network connectivity during resting state

  2. Functional magnetic resonance imaging (BOLD) [Baseline]

    cerebral pain related activation following evoked pressure pain stimuli

  3. Diffuse Tensor Imaging [Baseline]

    White matter microstructure (e.g. structural connectivity)

  4. Pressure pain thresholds [Baseline]

    Pressure allometry (mmHg)

  5. Temporal summation [Baseline]

    Pain ratings during repeated pressure stimuli, ratings from 0-100, with 100 being worst pain imaginable

Secondary Outcome Measures

  1. Pain intensity ratings [Baseline]

    Visual analogue scale, 0-100 mm, 100 mm, worst possible pain

  2. Oswestry Disability Index [Baseline]

    0-100, 0=no disability, 100= worst disability

  3. Fibromyalgia criteria-2016 revision (American College of Rheumatology) [Baseline]

    Calculation of FMness score, 0-31, 0 = no symptoms, 31 = worst symptoms

  4. Multidimensional Fatigue Inventory [Baseline]

    Total fatigue score, range 20-100, 100 = worst fatigue

  5. Pain catastrophizing scale [Baseline]

    Total score 0-52, high values more catastrophizing

  6. Beck Depression Inventory [Baseline]

    Scores 0-63, with 63 highest depression

  7. State-Trait Anxiety Inventory [Baseline]

    Scores 20-80 for state and 20-80 for trait anxiety, higher levels indicate more anxiety

  8. EuroQual-5D [Baseline]

    Scale ranging from -0.224 to 1, with 1 being highest possible health related quality of life

Eligibility Criteria

Criteria

Ages Eligible for Study:
30 Years to 60 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:Inclusion criteria:
  • 30-60 year

  • Right-handed

  • DDD patients: Radiologically verified DDD and DDD pain as their main pain complaint

Exclusion Criteria:
  • previous spine surgery

  • significant pain problems due to other causes and/or other chronic pain syndromes

  • inflammatory rheumatic diseases

  • neurological/psychiatric disorders

  • severe cardiovascular disease

  • substance abuse

  • BMI>40

  • Contraindication to MRI

Contacts and Locations

Locations

Site City State Country Postal Code
1 Karolinska Institute Stockholm Sweden 171 77
2 Karolinska Insitutet Stockholm Sweden

Sponsors and Collaborators

  • Karolinska Institutet

Investigators

  • Principal Investigator: Eva Kosek, Prof, MD, Karolinska Institutet

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Eva Kosek, Principal Investigator, Professor, MD, Karolinska Institutet
ClinicalTrials.gov Identifier:
NCT04934917
Other Study ID Numbers:
  • 2019-01142_1pre
First Posted:
Jun 22, 2021
Last Update Posted:
Jun 22, 2021
Last Verified:
Jun 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 22, 2021